Approaches for a tailored modeling of tumor-associated disease traits, such as immunologic disorders and inflammation, owing to ubiquitous accessible transcription pathways in tumor and neighboring stroma cells (IL-2 and IFN-α receptor, retinoid X and glucocorticoid receptor) have been intensively studied in RCC. Here, NR3C1 is linked to neoplasm.